| Literature DB >> 29694246 |
Abigail E Besemer1,2, You Ming Yang1,3, Joseph J Grudzinski1, Lance T Hall4,5, Bryan P Bednarz1.
Abstract
This work describes the development and validation of a patient-specific Monte Carlo internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for Internal Dosimetry). RAPID utilizes serial PET/CT or SPECT/CT images to calculate voxelized three-dimensional (3D) internal dose distributions with the Monte Carlo code Geant4. RAPID's dosimetry calculations were benchmarked against previously published S-values and specific absorbed fractions (SAFs) calculated for monoenergetic photon and electron sources within the Zubal phantom and for S-values calculated for a variety of radionuclides within spherical tumor phantoms with sizes ranging from 1 to 1000 g. The majority of the S-values and SAFs calculated in the Zubal Phantom were within 5% of the previously published values with the exception of a few 10 keV photon SAFs that agreed within 10%, and one value within 16%. The S-values calculated in the spherical tumor phantoms agreed within 2% for 177Lu, 131I, 125I, 18F, and 64Cu, within 3.5% for 211At and 213Bi, within 6.5% for 153Sm, 111In, 89Zr, and 223Ra, and within 9% for 90Y, 68Ga, and 124I. In conclusion, RAPID is capable of calculating accurate internal dosimetry at the voxel-level for a wide variety of radionuclides and could be a useful tool for calculating patient-specific 3D dose distributions.Entities:
Keywords: Monte Carlo; internal dosimetry; radiopharmaceuticals; targeted radionuclide therapy
Mesh:
Substances:
Year: 2018 PMID: 29694246 PMCID: PMC5963670 DOI: 10.1089/cbr.2018.2451
Source DB: PubMed Journal: Cancer Biother Radiopharm ISSN: 1084-9785 Impact factor: 3.099